Seagen discovers, develops, manufactures, and commercializes TCTs (targeted cancer therapeutics) with ADCs at our core.
Newsweek America’s Most Responsible Companies, Newsweek.com, 2023 Technology Fast 500, Deloitte’s Technology Fast 500, Deloitte, 2021 Biotech of the Year, Biopharma, 2020 Heroes of Chemistry, American Cancer Society (ACS), 2018 Corporate Leadership Award, Lymphoma Research Foundation, 2018